IVERSON GENETICS

Aug 11, 11
Other articles:
  • Sep 27, 2010 – The XT-8 allows fast processing and simple interpretation of patient results," stated Dean Sproles, CEO of Iverson Genetics. .
  • Bothell, WA, March 1, 2011 - Bothell, WA, March 1, 2011 -- Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study (Warfarin Adverse Event .
  • Click Here to read about genetics and inherited traits – this is the first learning target for the 4th quarter. Once on the website, scroll down to the .
  • Jul 10, 2008 – DNA Direct and Iverson Genetics Announce Partnership to Provide PersonalizedPatient Reports for Warfarin Dosing Test ResultsInteractive Tool .
  • File Format: PDF/Adobe Acrobat - Quick View
  • Mar 3, 2011 – Bothell's Iverson Genetic Diagnostics, Inc. announced that the WARFARIN Study ( Warfarin Adverse Event Reduction for Adults Receiving Genetic .
  • File Format: PDF/Adobe Acrobat - Quick View
  • File Format: PDF/Adobe Acrobat - Quick View
  • Aug 12, 2010 – Morehouse School of Medicine and Iverson Genetics partner in first-of-its-kind study to test how genetic information can help predict .
  • Mar 1, 2011 – BOTHELL, Wash., March 1, 2011 /PRNewswire/ -- Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study was initiated in .
  • Jul 26, 2010 – ATLANTA--(BUSINESS WIRE)-- Iverson Genetic Diagnostics today announced the company has received approval from CMS to conduct a WARFARIN .
  • Jul 14, 2010 – Iverson Genetics, an SC Launch company, is helping lead the way into the new era of personalized medicine. The company offers advanced .
  • Feb 23, 2007 – Biotech company trying to develop genetic tests which become the model for comprehensive disease detection and informed treatment.
  • Aug 7, 2010 – Iverson Genetic's PlaviSTAT training video for health care providers.
  • Mar 4, 2011 – Iverson Genetic Diagnostics has launched an 18-month study to assess the utility of genetic testing in determining the proper warfarin dose .
  • Nov 19, 2009 – Last week, NPR?s ?Morning Edition? did a story on the way companies and entrepreneurs are beginning to develop and market products tailored .
  • Jun 28, 2010 – Iverson's Clopidogrel GenoSTAT test identifies the genetic (CYP2C19) cause of an individual's PLAVIXTM resistance, detects mutation of the .
  • Mar 1, 2011 – BOTHELL, Wash., March 1, 2011 /PRNewswire/ -- Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study (Warfarin Adverse .
  • Iverson Genetic Diagnostics, Inc. 19805 North Creek Parkway Bothell, WA .
  • Iverson Genetic Diagnostics is helping lead the way into the new era of personalized medicine. Our headquarters is located in a 21456 square foot facility .
  • Mar 9, 2011 – Iverson Genetics will attempt to avoid the pitfalls of past warfarin PGx studies by returning genetic testing results within 24 hours to .
  • Welcome to the company profile of Iverson Genetics on LinkedIn. Iverson Genetics Diagnostics is helping lead the way in genetic testing to health care .
  • Apr 8, 2008 – Before its alliance with ParagonDx, Iverson Genetics used a . "We are proud to partner with Iverson Genetics to deliver the best in .
  • Apr 9, 2008 – Under the terms of the agreement, Iverson Genetics will use ParagonDx's products to test patients to determine if they possess genetic .
  • Iverson Genetics Company & Business Contact information- Jigsaw Business Directory. Get complete contact & company information with emails and phone numbers .
  • File Format: PDF/Adobe Acrobat - Quick View
  • Dec 2, 2009 – Iverson Genetic Diagnostics, Inc., a leader in the emerging field of gene-based health information, is opening a regional genetic testing .
  • File Format: PDF/Adobe Acrobat - Quick View
  • Sep 27, 2010 – Iverson Genetics has selected GenMark Diagnostics' eSensor Warfarin Sensitivity Test for use in its new pivotal clinical study, the Warfarin .
  • SC Launch Company Iverson Genetic Diagnostics receives CMS approval for Warfarin clinical study. Oct. 20, 2010. SCRA Press Release .
  • Morehouse School of Medicine (MSM) and Iverson Genetic Diagnostics recently announced that its WARFARIN Clinical Study has received approval from the .
  • Jul 28, 2010 – Iverson Genetics CEO Dean Sproles said that the warfarin study will . In conducting the study, Iverson Genetics aims to involve more than .
  • Iverson Genetics. Iverson is leading the way in genetic testing. They needed a brand that spoke to doctors as well as patients. We created a platform that .
  • Our mission is to develop genetic tests that will become the model for comprehensive disease detection and informed treatment, ushering in a new era of .
  • Jul 10, 2008 – SAN FRANCISCO and SEATTLE, July 10 /PRNewswire/ -- DNA Direct, Inc. and Iverson Genetic Diagnostics, Inc.
  • Biotech company trying to develop genetic tests which become the model for comprehensive disease detection and informed treatment.
  • Iverson Genetics - Company Overview: Iverson Genetic Diagnostics is helping lead the way into the new era of personalized medicine.
  • View key statistics about Iverson Genetics, including where Iverson Genetics .
  • Iverson Genetic Diagnostics is helping lead the way into the new era of .
  • Jul 14, 2010 – Iverson Genetics, an SC Launch company, is helping lead the way into the new era of personalized medicine. The company offers advanced .
  • Sep 17, 2008 – Notably, the story featured Iverson Genetic Diagnostics and their test for warfarin sensitivity. Warfarin (brand-name Coumadin®) is a .
  • DENVER--(BUSINESS WIRE)--Jul 28, 2011 - Iverson Genetic Diagnostics, Inc. announced that the WARFARIN Study (Warfarin Adverse Event Reduction for Adults .
  • The order online functionality of the Iverson website is currently under construction and will be made live soon. If you are interested in ordering test .
  • Jul 28, 2011 – DENVER--(EON: Enhanced Online News)--Iverson Genetic Diagnostics, Inc. announced that the WARFARIN Study (Warfarin Adverse Event Reduction .
  • File Format: PDF/Adobe Acrobat - Quick View
  • Act in the best interests of patient care and Iverson Genetic Diagnostics .
  • Sep 11, 2008 – Seated at a lab bench at Iverson Genetics Diagnostics, . Dr. RISHMA JOSHI ( Iverson Genetics Diagnostics): We need to get the DNA from the .
  • Jul 28, 2010 – Iverson Genetics CEO Dean Sproles said that the warfarin study will use Genmark's eSensor Warfarin Sensitivity Test, which has been cleared .
  • May 15, 2008 – A rough edit of John Baek's interview with Kendra Keys.

    • Sitemap